» Articles » PMID: 23874276

Behavioral and Biochemical Evidence of the Role of Acetaldehyde in the Motivational Effects of Ethanol

Overview
Specialty Psychology
Date 2013 Jul 23
PMID 23874276
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Since Chevens' report, in the early 50's that his patients under treatment with the aldehyde dehydrogenase inhibitor, antabuse, could experience beneficial effects when drinking small volumes of alcoholic beverages, the role of acetaldehyde (ACD) in the effects of ethanol has been thoroughly investigated on pre-clinical grounds. Thus, after more than 25 years of intense research, a large number of studies have been published on the motivational properties of ACD itself as well as on the role that ethanol-derived ACD plays in the effects of ethanol. Accordingly, in particular with respect to the motivational properties of ethanol, these studies were developed following two main strategies: on one hand, were aimed to challenge the suggestion that also ACD may exert motivational properties on its own, while, on the other, with the aid of enzymatic manipulations or ACD inactivation, were aimed to test the hypothesis that ethanol-derived ACD might have a role in ethanol motivational effects. Furthermore, recent evidence significantly contributed to highlight, as possible mechanisms of action of ACD, its ability to commit either dopaminergic and opioidergic transmission as well as to activate the Extracellular signal Regulated Kinase cascade transduction pathway in reward-related brain structures. In conclusion, and despite the observation that ACD seems also to have inherited the elusive nature of its parent compound, the behavioral and biochemical evidence reviewed points to ACD as a neuroactive molecule able, on its own and as ethanol metabolite, to exert motivational effects.

Citing Articles

Alcohol metabolism in alcohol use disorder: a potential therapeutic target.

Lehner T, Gao B, Mackowiak B Alcohol Alcohol. 2023; 59(1).

PMID: 37950904 PMC: 10783952. DOI: 10.1093/alcalc/agad077.


Acetaldehyde Induces Neurotoxicity via Oxidative Stress- and Ca Imbalance-Mediated Endoplasmic Reticulum Stress.

Cui J, Liu Y, Chang X, Gou W, Zhou X, Liu Z Oxid Med Cell Longev. 2019; 2019:2593742.

PMID: 30728884 PMC: 6343137. DOI: 10.1155/2019/2593742.


GABA receptor polymorphisms in alcohol use disorder in the GWAS era.

Koulentaki M, Kouroumalis E Psychopharmacology (Berl). 2018; 235(6):1845-1865.

PMID: 29721579 DOI: 10.1007/s00213-018-4918-4.


Mystic Acetaldehyde: The Never-Ending Story on Alcoholism.

Peana A, Sanchez-Catalan M, Hipolito L, Rosas M, Porru S, Bennardini F Front Behav Neurosci. 2017; 11:81.

PMID: 28553209 PMC: 5425597. DOI: 10.3389/fnbeh.2017.00081.


From Ethanol to Salsolinol: Role of Ethanol Metabolites in the Effects of Ethanol.

Peana A, Rosas M, Porru S, Acquas E J Exp Neurosci. 2016; 10:137-146.

PMID: 27891052 PMC: 5117487. DOI: 10.4137/JEN.S25099.


References
1.
Spivak K, Aragon C, Amit Z . Alterations in brain aldehyde dehydrogenase activity modify ethanol-induced conditioned taste aversion. Alcohol Clin Exp Res. 1987; 11(6):513-7. DOI: 10.1111/j.1530-0277.1987.tb00163.x. View

2.
Fasano S, Brambilla R . Ras-ERK Signaling in Behavior: Old Questions and New Perspectives. Front Behav Neurosci. 2011; 5:79. PMC: 3223382. DOI: 10.3389/fnbeh.2011.00079. View

3.
Aragon C, Amit Z . The effect of 3-amino-1,2,4-triazole on voluntary ethanol consumption: evidence for brain catalase involvement in the mechanism of action. Neuropharmacology. 1992; 31(7):709-12. DOI: 10.1016/0028-3908(92)90150-n. View

4.
Valjent E, Pages C, Herve D, Girault J, Caboche J . Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci. 2004; 19(7):1826-36. DOI: 10.1111/j.1460-9568.2004.03278.x. View

5.
Xie G, Ye J . Salsolinol facilitates glutamatergic transmission to dopamine neurons in the posterior ventral tegmental area of rats. PLoS One. 2012; 7(5):e36716. PMC: 3349709. DOI: 10.1371/journal.pone.0036716. View